Applied DNA Sciences (APDN) Misses Q4 EPS by 1c
Get Alerts APDN Hot Sheet
Price: $0.34 --0%
EPS Growth %: -540.0%
Financial Fact:
Revenue: 1.64M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -540.0%
Financial Fact:
Revenue: 1.64M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.79 million.
Excluding non-cash expenses, Adjusted EBITDA for the quarter ended September 30, 2016 was negative $1.7 million compared to a positive Adjusted EBITDA of $213 thousand for the same quarter last year and a negative Adjusted EBITDA of $2.6 million in the prior fiscal quarter.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
- Super Micro Computer (SMCI) now down nearly 20%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!